BeyondSpring Inc.
- BYSI
- NASDAQ
- Biotechnology
- Cancer Immunotherapy
- Clinical-Stage Biotech
$0.56
Today −3.90%Quote Oct 16, 2026, 08:00 PM UTC
−21.11%over the last month
Max drawdown −50.1%From 1-month high −50.1%3 months −54.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$23.0M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.55
2.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BYSIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
44
Founded
2010